[Standard Chemical & Pharmaceutical Co., Ltd.] 2026 Q1 EPS NT$1.30
NQ Score
0/100
N1 Content Completeness
0
AI Summary (NQ-processed)
Standard Chemical & Pharmaceutical announced its Q1 2026 results, recording an EPS of NT$1.30, revenue of NT$1.652 billion, and net income after tax of NT$0.299 billion. This indicates the company's solid performance.